Perceptive Advisors LLC bought a new stake in shares of Rapport Therapeutics (NASDAQ:RAPP – Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The fund bought 748,183 shares of the company's stock, valued at approximately $17,403,000. Perceptive Advisors LLC…
